Sk Bioscience | search
Click here to view Sk Bioscience news from 60+ newspapers.
Bookmark or Share- SK bioscienceSK bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline. The company will expand its manufacturing plant, L HOUSE, with additional cGMP-level facility.The ne... 2024.03.07. SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine.
- SK bioscienceSK bioscience is a vaccine company spun off from SK chemicals in 2018. Since 2008 before the spin-off from SK chemicals, we focused on premium vaccines as new-driving forces for growth. We continued to invest in production and manufacturing infrastructure.
- SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the ...SEONGNAM, South Korea, June 19, 2023 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced the...
- SK bioscienceSK bioscience. QUICK. SK bioscience is growing as a global vaccine developer through continuous investments to R&D and manufacturing infrastructure. Message from the CEO. From prevention to Cure, SK bioscience is hereto promote human health. Jaeyong Ahn. President and Chief Executive Officer, SK bioscience. Greetings!
- SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 ...31 August 2021. SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate. For media and investors only. Issued: London, UK and Seoul, Republic of Korea. Advance to Phase 3 follows positive interim Phase 1/2 immunogenicity and safety data.
More
